Form 4 for HCAT Health Catalyst, Inc.
Accepted 2021-12-29 00:00:00 ET · period of report 2021-12-27 · accession 0001562180-21-007902 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-12-29 | 2021-12-27 | HCAT | Hinton Bryan Richard | CTO | M - OptEx | $10.80 | +260 | 9,635 | +3% | +$2,808 |
| D | 2021-12-29 | 2021-12-27 | HCAT | Hinton Bryan Richard | CTO | S - Sale+OE | $39.56 | -260 | 9,375 | -3% | -$10.3K |
| D | 2021-12-29 | 2021-12-27 | HCAT | Hinton Bryan Richard | CTO | M - OptEx | $0.00 | -260 | 2,340 | -10% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-12-27 | M | A | 260 | $10.80 | 9,635 | D | — | — | |
| 2 | Common | Common Stock | 2021-12-27 | S | D | 260 | $39.56 | 9,375 | D | — | — | |
| 3 | Derivative | Stock Option (Right to Buy) | 2021-12-27 | M | D | 260 | $0.00 | 2,340 | D | $10.80 · — to 2028-09-27 | 260 Common Stock | (F2) 25% of the 12,500 shares underlying the option vested in an annual installment and the remaining balance vested or will vest in equal monthly installments until the option vests in full on September 25, 2022. |